LeadIQ logo
Learn more at LeadIQ.com

Insights

Strategic Partnerships Biohaven's recent partnership with Regeneron Pharmaceuticals presents an opportunity for cross-selling products and services to a wider market through collaboration with a well-established player in the industry.

Investor Interest The investments made by GSA Capital Partners LLP and ProFunds Distributors, Inc. demonstrate investor confidence in Biohaven. Leveraging this financial backing can attract more investors and expand business operations.

Competitor Analysis Identified as a competitor to Argenx, Biohaven's rapid growth and innovative therapies position it as a strong contender in the biotechnology market, presenting an opportunity to highlight unique selling propositions compared to competitors.

Milestone Achievements Biohaven's successful completion of a biomarker study, formulation development, and initiation of Phase 3 studies for BHV-7000 indicate significant progress. Using these milestones as leverage can attract potential partners and investors.

Industry Collaboration Partnering with UniSC Clinical Trials for conducting migraine treatment trials showcases Biohaven's commitment to research and development. Collaborating with research institutions can lead to more opportunities for clinical trials and product advancements.

Similar companies to Biohaven

Biohaven Tech Stack

Biohaven uses 8 technology products and services including CookieYes, prettyPhoto, Webpack, and more. Explore Biohaven's tech stack below.

  • CookieYes
    Cookie Compliance
  • prettyPhoto
    Javascript Libraries
  • Webpack
    Miscellaneous
  • Open Graph
    Miscellaneous
  • Yoast SEO
    Search Engines
  • Akamai Bot Manager
    Security
  • Adobe Tag Manager
    Tag Management
  • Google Tag Manager
    Tag Management

Biohaven's Email Address Formats

Biohaven uses at least 2 format(s):
Biohaven Email FormatsExamplePercentage
First.Last@biohavenpharma.comJohn.Doe@biohavenpharma.com
97%
Last.First@biohavenpharma.comDoe.John@biohavenpharma.com
1%
First.L@biohavenpharma.comJohn.D@biohavenpharma.com
1%
FirstLast@biohavenpharma.comJohnDoe@biohavenpharma.com
1%
FLast@biohaven.comJDoe@biohaven.com
76%
First.Last@biohaven.comJohn.Doe@biohaven.com
17%
Last@biohaven.comDoe@biohaven.com
7%

Frequently Asked Questions

Where is Biohaven's headquarters located?

Minus sign iconPlus sign icon
Biohaven's main headquarters is located at 215 Church Street New Haven, CT 06510 US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Biohaven's phone number?

Minus sign iconPlus sign icon
You can contact Biohaven's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Biohaven's stock symbol?

Minus sign iconPlus sign icon
Biohaven is a publicly traded company; the company's stock symbol is BHVN.

What is Biohaven's official website and social media links?

Minus sign iconPlus sign icon
Biohaven's official website is biohaven.com and has social profiles on LinkedIn.

How much revenue does Biohaven generate?

Minus sign iconPlus sign icon
As of September 2024, Biohaven's annual revenue reached $75M.

What is Biohaven's SIC code NAICS code?

Minus sign iconPlus sign icon
Biohaven's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Biohaven have currently?

Minus sign iconPlus sign icon
As of September 2024, Biohaven has approximately 475 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: D. D.Chief Scientific Officer: B. C.Chief Technology Officer: J. M.. Explore Biohaven's employee directory with LeadIQ.

What industry does Biohaven belong to?

Minus sign iconPlus sign icon
Biohaven operates in the Biotechnology Research industry.

What technology does Biohaven use?

Minus sign iconPlus sign icon
Biohaven's tech stack includes CookieYesprettyPhotoWebpackOpen GraphYoast SEOAkamai Bot ManagerAdobe Tag ManagerGoogle Tag Manager.

What is Biohaven's email format?

Minus sign iconPlus sign icon
Biohaven's email format typically follows the pattern of . Find more Biohaven email formats with LeadIQ.

How much funding has Biohaven raised to date?

Minus sign iconPlus sign icon
As of September 2024, Biohaven has raised $265M in funding. The last funding round occurred on Apr 18, 2024 for $265M.

When was Biohaven founded?

Minus sign iconPlus sign icon
Biohaven was founded in 2022.
Biohaven

Biohaven

Biotechnology ResearchConnecticut, United States201-500 Employees

Biohaven is a uniquely different pharmaceutical company. We are an agile and resilient team of highly skilled professionals who eagerly challenge the status quo to advance novel, life-changing therapies. People are at the center of all we do. The unmet needs of patients inspire us to follow scientific innovation wherever it leads and motivates our resolve for overcoming the obstacles that stand in the way of medical progress. It is all part of the patient-first culture we proudly call the “Biohaven Way.”

If you’d like to join us, please visit our Careers page:  https://www.biohaven.com/careers/

For Investor news and financial information about Biohaven (NYSE: BHVN): https://ir.biohaven.com/

View our Pipeline:  https://www.biohaven.com/pipeline/

Section iconCompany Overview

Headquarters
215 Church Street New Haven, CT 06510 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
BHVN
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2022
Employees
201-500

Section iconFunding & Financials

  • $265M

    Biohaven has raised a total of $265M of funding over 2 rounds. Their latest funding round was raised on Apr 18, 2024 in the amount of $265M.

  • $50M$100M

    Biohaven's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $265M

    Biohaven has raised a total of $265M of funding over 2 rounds. Their latest funding round was raised on Apr 18, 2024 in the amount of $265M.

  • $50M$100M

    Biohaven's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.